NBTK.DE vs. XGEN.DE
NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) are both Health & Biotech Equities funds - NBTK.DE tracks the Nasdaq Biotechnology while XGEN.DE tracks the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. Both are passively managed. Over the past 3 years, NBTK.DE returned 9.94%/yr vs 1.39%/yr for XGEN.DE. Their correlation of 0.81 suggests significant overlap in exposure. NBTK.DE charges 0.40%/yr vs 0.30%/yr for XGEN.DE.
Performance
NBTK.DE vs. XGEN.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly higher than XGEN.DE's -1.40% return.
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
XGEN.DE
- 1D
- 3.92%
- 1M
- 5.33%
- YTD
- -1.40%
- 6M
- -3.45%
- 1Y
- 22.88%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
NBTK.DE vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | 0.90% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
Correlation
The correlation between NBTK.DE and XGEN.DE is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.81 |
The correlation between NBTK.DE and XGEN.DE has been stable across timeframes, ranging from 0.81 to 0.84 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBTK.DE vs. XGEN.DE — Risk / Return Rank
NBTK.DE
XGEN.DE
NBTK.DE vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBTK.DE | XGEN.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.80 | ||
| Sortino ratioReturn per unit of downside risk | +1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.21 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 1.49 | +4.68 |
| Martin ratioReturn relative to average drawdown | 17.06 | 3.61 | +13.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBTK.DE | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 1.23 | +0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | -0.11 | +0.52 |
Drawdowns
NBTK.DE vs. XGEN.DE - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum XGEN.DE drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and XGEN.DE.
Loading charts...
Drawdown Indicators
| NBTK.DE | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.99% | -37.58% | +6.59% |
Max Drawdown (1Y)Largest decline over 1 year | -6.24% | -14.99% | +8.75% |
Max Drawdown (3Y)Largest decline over 3 years | -29.35% | -28.21% | -1.14% |
Max Drawdown (5Y)Largest decline over 5 years | -30.99% | — | — |
Current DrawdownCurrent decline from peak | -1.44% | -14.86% | +13.42% |
Average DrawdownAverage peak-to-trough decline | -10.62% | -19.44% | +8.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.26% | 6.19% | -3.93% |
Volatility
NBTK.DE vs. XGEN.DE - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) have volatilities of 6.41% and 6.48%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBTK.DE | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 6.48% | -0.07% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 13.73% | +0.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.00% | 18.19% | +0.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.30% | 18.66% | +1.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.05% | 18.66% | +3.39% |
NBTK.DE vs. XGEN.DE - Expense Ratio Comparison
NBTK.DE has a 0.40% expense ratio, which is higher than XGEN.DE's 0.30% expense ratio.
Dividends
NBTK.DE vs. XGEN.DE - Dividend Comparison
Neither NBTK.DE nor XGEN.DE has paid dividends to shareholders.
Frequently Asked Questions
NBTK.DE and XGEN.DE have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XGEN.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XGEN.DE is cheaper with a 0.30% expense ratio, compared with 0.40% for NBTK.DE.
NBTK.DE tracks Nasdaq Biotechnology, while XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. They also come from different issuers: Invesco and Xtrackers. Their fees differ too: 0.40% for NBTK.DE and 0.30% for XGEN.DE.
Find the right allocation for NBTK.DE and XGEN.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer